Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02472171 · ClinicalTrials.gov registry record · NA
Suppression of Postprandial Monocyte Activation by Blueberries or Docosahexaenoic Acid in Humans
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02472171 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 62 participants.
The verdict
NCT02472171, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The overall goal of the research study is to determine whether a high-fat meal causes postprandial (after meal) inflammation, and whether eating n-3 polyunsaturated fatty acids (PUFAs) or blueberries that are rich in anti-inflammatory polyphenols suppress the inflammation in healthy people.
Interventions
- DIETARY_SUPPLEMENT High saturated fat meal, placebo powder and sunflower oil
- DIETARY_SUPPLEMENT High saturated fat meal, blueberry powder and sunflower oil
- DIETARY_SUPPLEMENT High saturated fat meal, placebo powder and DHA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02472171
The ClinicalTrials.gov registry entry for NCT02472171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA, Western Human Nutrition Research Center, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which High saturated fat meal, placebo powder and sunflower oil is the first listed.
NCT02472171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02472171 about?
NCT02472171 is a clinical study titled "Suppression of Postprandial Monocyte Activation by Blueberries or Docosahexaenoic Acid in Humans". The overall goal of the research study is to determine whether a high-fat meal causes postprandial (after meal) inflammation, and whether eating n-3 polyunsaturated fatty acids (PUFAs) or blueberries that are rich in anti-inflammatory polyphenols suppress the inflammation in healthy people.
What is the current status of trial NCT02472171?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2015-06. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02472171?
The interventions under investigation include: High saturated fat meal, placebo powder and sunflower oil (DIETARY_SUPPLEMENT), High saturated fat meal, blueberry powder and sunflower oil (DIETARY_SUPPLEMENT), High saturated fat meal, placebo powder and DHA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02472171?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.